These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 9134449

  • 1. The effects of nitric oxide synthase inhibitor, L-NAME on NO production during focal cerebral ischemia in rats: could L-NAME be the future treatment of sudden deafness?
    Balkan E, Balkan S, Ozben T, Serteser M, Gümüslü S, Oguz N.
    Int J Neurosci; 1997 Jan; 89(1-2):61-77. PubMed ID: 9134449
    [Abstract] [Full Text] [Related]

  • 2. Inhibitory role of N omega-nitro-L-arginine methyl ester (L-NAME), a potent nitric oxide synthase inhibitor, on brain malondialdehyde and conjugated diene levels during focal cerebral ischemia in rats.
    Gümüşlü S, Serteser M, Ozben T, Balkan S, Balkan E.
    Clin Chim Acta; 1997 Nov 28; 267(2):213-23. PubMed ID: 9469254
    [Abstract] [Full Text] [Related]

  • 3. Antioxidant effect of N omega-nitro-L-arginine methyl ester (L-NAME) on global cerebral ischemia in a rat model.
    Seif-el-Nasr M, Fahim AT.
    Arzneimittelforschung; 2001 Nov 28; 51(8):628-32. PubMed ID: 11556122
    [Abstract] [Full Text] [Related]

  • 4. Effects of Lamotrigine on brain nitrite and cGMP levels during focal cerebral ischemia in rats.
    Balkan S, Ozben T, Balkan E, Oguz N, Serteser M, Gümüslü S.
    Acta Neurol Scand; 1997 Mar 28; 95(3):140-6. PubMed ID: 9088381
    [Abstract] [Full Text] [Related]

  • 5. Nitric oxide production during focal cerebral ischemia in rats.
    Kader A, Frazzini VI, Solomon RA, Trifiletti RR.
    Stroke; 1993 Nov 28; 24(11):1709-16. PubMed ID: 7694393
    [Abstract] [Full Text] [Related]

  • 6. Resveratrol neuroprotective effects during focal cerebral ischemia injury via nitric oxide mechanism in rats.
    Tsai SK, Hung LM, Fu YT, Cheng H, Nien MW, Liu HY, Zhang FB, Huang SS.
    J Vasc Surg; 2007 Aug 28; 46(2):346-53. PubMed ID: 17600658
    [Abstract] [Full Text] [Related]

  • 7. Behavioural, neurochemical and neuroanatomical effects of chronic postnatal N-nitro-L-arginine methyl ester treatment in neonatal and adult rats.
    Prickaerts J, De Vente J, Markerink-Van Ittersum M, Steinbusch HW.
    Neuroscience; 1998 Nov 28; 87(1):181-95. PubMed ID: 9722151
    [Abstract] [Full Text] [Related]

  • 8. Effects of VEGF and nitric oxide synthase inhibition on blood-brain barrier disruption in the ischemic and non-ischemic cerebral cortex.
    Chi OZ, Hunter C, Liu X, Weiss HR.
    Neurol Res; 2005 Dec 28; 27(8):864-8. PubMed ID: 16354548
    [Abstract] [Full Text] [Related]

  • 9. Effects of chronic L-NAME treatment on rat focal cerebral ischemia and cerebral vasoreactivity.
    Sercombe R, Issertial O, Seylaz J, Pinard E.
    Life Sci; 2001 Sep 28; 69(19):2203-16. PubMed ID: 11669463
    [Abstract] [Full Text] [Related]

  • 10. Anti-ischaemic efficacy of a nitric oxide synthase inhibitor and a N-methyl-D-aspartate receptor antagonist in models of transient and permanent focal cerebral ischaemia.
    Dawson DA, Graham DI, McCulloch J, Macrae IM.
    Br J Pharmacol; 1994 Sep 28; 113(1):247-53. PubMed ID: 7529111
    [Abstract] [Full Text] [Related]

  • 11. Modulation of cerebral RAGE expression following nitric oxide synthase inhibition in rats subjected to focal cerebral ischemia.
    Greco R, Demartini C, Zanaboni AM, Blandini F, Amantea D, Tassorelli C.
    Eur J Pharmacol; 2017 Apr 05; 800():16-22. PubMed ID: 28188764
    [Abstract] [Full Text] [Related]

  • 12. Brain nitrite production during global ischemia and reperfusion: an in vivo microdialysis study.
    Shibata M, Araki N, Hamada J, Sasaki T, Shimazu K, Fukuuchi Y.
    Brain Res; 1996 Sep 23; 734(1-2):86-90. PubMed ID: 8896812
    [Abstract] [Full Text] [Related]

  • 13. L-NAME reduces infarction, neurological deficit and blood-brain barrier disruption following cerebral ischemia in mice.
    Ding-Zhou L, Marchand-Verrecchia C, Croci N, Plotkine M, Margaill I.
    Eur J Pharmacol; 2002 Dec 20; 457(2-3):137-46. PubMed ID: 12464359
    [Abstract] [Full Text] [Related]

  • 14. Nitric-oxide-synthase-mediated cyclic guanosine monophosphate production in neonatal rat cerebellar prisms is resistant to calcineurin inhibition.
    Macleod MR, Butcher SP.
    Neurosci Lett; 2002 Mar 29; 322(1):41-4. PubMed ID: 11958839
    [Abstract] [Full Text] [Related]

  • 15. Caveolin-1 regulates nitric oxide-mediated matrix metalloproteinases activity and blood-brain barrier permeability in focal cerebral ischemia and reperfusion injury.
    Gu Y, Zheng G, Xu M, Li Y, Chen X, Zhu W, Tong Y, Chung SK, Liu KJ, Shen J.
    J Neurochem; 2012 Jan 29; 120(1):147-56. PubMed ID: 22007835
    [Abstract] [Full Text] [Related]

  • 16. A comparison of the effects of L-NAME, 7-NI and L-NIL on carrageenan-induced hindpaw oedema and NOS activity.
    Handy RL, Moore PK.
    Br J Pharmacol; 1998 Mar 29; 123(6):1119-26. PubMed ID: 9559895
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of vascular nitric oxide after rat chronic brain hypoperfusion: spatial memory and immunocytochemical changes.
    de la Torre JC, Aliev G.
    J Cereb Blood Flow Metab; 2005 Jun 29; 25(6):663-72. PubMed ID: 15703700
    [Abstract] [Full Text] [Related]

  • 18. [Effect of nitric oxide synthase inhibitor L-NAME on the induction of brain ischemic tolerance in rats].
    Liu HQ, Li WB, Feng RF, Li QJ, Chen XL, Zhou AM, Zhao HG, Ai J.
    Sheng Li Xue Bao; 2003 Apr 25; 55(2):219-24. PubMed ID: 12715115
    [Abstract] [Full Text] [Related]

  • 19. Differential role of nitric oxide pathway and heat shock protein in preconditioning and lipopolysaccharide-induced brain ischemic tolerance.
    Puisieux F, Deplanque D, Pu Q, Souil E, Bastide M, Bordet R.
    Eur J Pharmacol; 2000 Feb 11; 389(1):71-8. PubMed ID: 10686298
    [Abstract] [Full Text] [Related]

  • 20. Sildenafil citrate attenuates a complex maze impairment induced by intracerebroventricular infusion of the NOS inhibitor Nomega-nitro-L-arginine methyl ester.
    Devan BD, Pistell PJ, Daffin LW, Nelson CM, Duffy KB, Bowker JL, Bharati IS, Sierra-Mercado D, Spangler EL, Ingram DK.
    Eur J Pharmacol; 2007 Jun 01; 563(1-3):134-40. PubMed ID: 17362916
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.